ETFs Holding LBIO »    LBIO Historical Stock Prices »
LBIO News Video: Wed, Oct 7, 2015, 1:52 PM — Wednesday Sector Leaders: Biotechnology, General Contractors & Builders

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lion Biotechnologies is a development stage biotechnology company focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes (TILs) for the treatment of metastatic melanoma and other solid cancers. ACT utilizes T-cells harvested from a patient to treat cancer in that patient. TIL are collected from individual patient tumor samples. The TIL are then activated and expanded ex vivo and then infused back into the patient to fight their tumor cells. Co.'s product pipeline includes: LN-144, which is for the treatment of metastatic melanoma; and LN-145, which is for the treatment of cervical and head and neck cancers. Self directed investors in Iovance Biotherapeutics Inc will be interested in keeping up with all Iovance Biotherapeutics Inc news they can find, both LBIO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on LBIO. At RediNews, we simplify this task by presenting both LBIO news releases originating from Iovance Biotherapeutics Inc itself, and LBIO news from a variety of media outlets. Visitors can browse this news online and through our LBIO RSS news feed.


LBIO News — Articles, Videos, & Press Releases

LBIO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

AST News

RediNews would like to be your web content provider of choice for news feeds by stock ticker symbol, or by market sector. An ideal complement to other financial content like stock quotes and charts, our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . There is no charge to use our feeds, they are available to you for free.

LBIO News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.